INIS
blood-brain barrier
100%
glioblastomas
100%
delivery
100%
clinical trials
100%
brain
75%
drugs
66%
concentration
58%
albumins
50%
humans
50%
patients
33%
diseases
16%
skull
16%
therapy
16%
gliomas
16%
safety
16%
cancer
8%
bypasses
8%
levels
8%
solvents
8%
tissues
8%
surgery
8%
toxicity
8%
mice
8%
infusion
8%
vehicles
8%
control
8%
nmr imaging
8%
volume
8%
tumors
8%
compartments
8%
assessments
8%
administration
8%
devices
8%
microtubules
8%
margins
8%
failures
8%
injection
8%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
100%
Paclitaxel
100%
Glioblastoma
100%
Clinical Trial
100%
Drug
50%
Albumin
41%
Carboplatin
25%
Human
16%
Cremophor
16%
Glioma
16%
Diseases
16%
Mouse
8%
Survival
8%
Malignant Neoplasm
8%
IC50
8%
Pharmaceutical Therapy
8%
Solvent
8%
Toxicity
8%
Neoplasm
8%
Drug Concentration
8%
Temozolomide
8%
Progression Free Survival
8%
Biochemistry, Genetics and Molecular Biology
Blood Brain Barrier
100%
Ultrasound
100%
Human
16%
Magnetic Resonance Imaging
8%
Drug Penetration
8%
Volume
8%
Solvent
8%
Drug Concentration
8%
Progression Free Survival
8%
Mouse
8%
IC50
8%
Survival
8%